10.3390/ijms24032642 7 ChoiH
Targeted Weight Management Designed for individuals seeking a medical solution to support their weight loss goals
Gene expression studies show it activates DNA repair genes and tumor suppressors like p53 while dialing down genes linked to metastasis
They are: BMI 35 or higher (no additional condition required) BMI 30 to 34.9 with heart failure, uncontrolled hypertension, or chronic kidney disease BMI 27 to 29.9 with prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease Our Medicare GLP-1 Bridge eligibility tiers post covers each tier in detail, including the documentation the central processor will look for
PlexusDx offers the Precision Peptide Genetic Test, which identifies genetic variants in the GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 medications